Insider Profile
Mullally, William Hogan
1
Companies Filed At
0
Open-Market Buys (2yr)
Buy Value (2yr, open-market)
Jun 01, 2026
Most Recent Trade
Date Company Role Nature Dir. Shares Price Value Score
Jun 01, 2026 $TTI
Thiogenesis Therapeutics, Corp.
Open Market Sell 150,000 $0.50 $75K
Sep 11, 2025 $TTI
Thiogenesis Therapeutics, Corp.
Comp. Grant Buy 75,000 $0.75 $56K
Jul 30, 2025 $TTI
Thiogenesis Therapeutics, Corp.
Open Market Sell 64,000 $0.75 $48K
Mar 31, 2022 $TTI
Thiogenesis Therapeutics, Corp.
Comp. Grant Buy 450,000 $0.35 $158K
Mar 30, 2022 $TTI
Thiogenesis Therapeutics, Corp.
Exercise Sell 125,000 $0.10 $12K
Mar 30, 2022 $TTI
Thiogenesis Therapeutics, Corp.
Exercise Buy 125,000 $0.10 $12K
Muted rows are plan purchases, compensation grants, or DRIP — not open-market. Confluence Scores reflect the company's current score, not the score at time of trade.
Form55 provides data and analysis for informational purposes only. Nothing on this site constitutes investment advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.